Article info

Download PDFPDF

2022-RA-820-ESGO The role of minimally invasive secondary cytoreduction in recurrent ovarian cancer patients

Authors

Citation

Conte C, Marchetti C, Loverro M, et al
2022-RA-820-ESGO The role of minimally invasive secondary cytoreduction in recurrent ovarian cancer patients

Publication history

  • First published October 20, 2022.
Online issue publication 
October 27, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.